Treatment Effect According to Timing of Administration of DWP14012 40 mg

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The primary objective of this study is to establish noninferiority of efficacy of DWP14012 (40 mg once daily) based on Timing of Administration.
Epistemonikos ID: 56e252a248b12b672b19abe029765028b147198e
First added on: May 07, 2024